← Back to Analyst Consensus 
CNTA Hold
Centessa Pharmaceuticals plc
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Apr 20, 2026 | Wells Fargo | downgrade | Overweight → Equal-Weight | — | 54% |
| Apr 2, 2026 | Guggenheim | downgrade | Buy → Neutral | — | 52% |
| Apr 1, 2026 | Leerink Partners | downgrade | Outperform → Market Perform | — | 51% |
| Mar 31, 2026 | Wolfe Research | downgrade | Outperform → Peer Perform | — | 53% |
| Mar 31, 2026 | Needham | downgrade | Buy → Hold | — | 50% |
| Feb 24, 2026 | Wolfe Research | initiate | — → Outperform | $40 | 53% |
| Jan 29, 2026 | Truist Securities | maintain | Buy → Buy | $38 | 54% |
| Jan 8, 2026 | Truist Securities | maintain | Buy → Buy | $33 | 54% |
| Jan 2, 2026 | Chardan Capital | maintain | Buy → Buy | $30 | 47% |
| Dec 10, 2025 | Oppenheimer | maintain | Outperform → Outperform | $62 | 52% |
| Dec 1, 2025 | B. Riley Securities | maintain | Buy → Buy | $42 | 54% |
| Nov 18, 2025 | Guggenheim | maintain | Buy → Buy | $43 | 52% |
| Nov 13, 2025 | Wells Fargo | maintain | Overweight → Overweight | $35 | 54% |
| Nov 7, 2025 | Wells Fargo | maintain | Overweight → Overweight | $30 | 54% |
| Oct 28, 2025 | Stephens & Co. | initiate | — → Overweight | $35 | 54% |
| Oct 6, 2025 | Guggenheim | reiterate | Buy → Buy | $28 | 52% |
| Sep 3, 2025 | Wells Fargo | initiate | — → Overweight | $31 | 54% |
| Aug 12, 2025 | Chardan Capital | maintain | Buy → Buy | $30 | 47% |
| Jul 30, 2025 | Chardan Capital | maintain | Buy → Buy | $30 | 47% |
| Jul 21, 2025 | Truist Securities | initiate | — → Buy | $30 | 54% |
| May 28, 2025 | Needham | initiate | — → Buy | $35 | 50% |
| May 8, 2025 | Chardan Capital | initiate | — → Buy | $30 | 47% |
| Mar 31, 2025 | Piper Sandler | initiate | — → Overweight | $38 | 54% |
| Mar 26, 2025 | Guggenheim | reiterate | Buy → Buy | $28 | 52% |
| Feb 10, 2025 | Guggenheim | reiterate | Buy → Buy | $0 | 52% |
| Jan 7, 2025 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Nov 15, 2024 | Guggenheim | maintain | Buy → Buy | $28 | 52% |
| Sep 19, 2024 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $26 | 54% |
| Sep 19, 2024 | B. Riley Securities | initiate | — → Buy | $33 | 54% |
| Sep 16, 2024 | BMO Capital | maintain | Outperform → Outperform | $35 | 53% |
| Sep 11, 2024 | Guggenheim | maintain | Buy → Buy | $24 | 52% |
| Sep 11, 2024 | Jefferies | maintain | Buy → Buy | $19 | 52% |
| Sep 9, 2024 | BMO Capital | maintain | Outperform → Outperform | $20 | 53% |
| Aug 14, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $14 | 52% |
| Jul 18, 2024 | Oppenheimer | initiate | — → Outperform | $14 | 52% |
| Jun 21, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $11 | 54% |
| Apr 1, 2024 | BMO Capital | maintain | Outperform → Outperform | $15 | 53% |
| Nov 15, 2023 | Jefferies | upgrade | Hold → Buy | $11 | 52% |
| Oct 26, 2023 | Morgan Stanley | upgrade | Underweight → Equal-Weight | $8 | 54% |
| Aug 15, 2023 | Guggenheim | maintain | Buy → Buy | $10 | 52% |
| Aug 15, 2023 | Goldman Sachs | maintain | Neutral → Neutral | $5 | 54% |
| Aug 15, 2023 | SVB Securities | maintain | Outperform → Outperform | $11 | — |
| Jul 25, 2023 | BMO Capital | maintain | Outperform → Outperform | $15 | 53% |
| Jun 21, 2023 | Evercore ISI Group | initiate | — → Outperform | $0 | 58% |
| Jun 12, 2023 | Guggenheim | initiate | — → Buy | $9 | 52% |
| May 15, 2023 | Goldman Sachs | maintain | Neutral → Neutral | $4.5 | 54% |
| Mar 17, 2023 | SVB Leerink | initiate | — → Outperform | $6 | — |
| Jan 24, 2023 | Morgan Stanley | maintain | — → Underweight | $4 | 54% |
| Aug 12, 2022 | Morgan Stanley | downgrade | Overweight → Underweight | $5 | 54% |
Price Target Trend
Mar 27, 2026 Latest: $40.25 Aug 24, 2026
EPS Estimates
+1y $-1.78
Lo: $-2.06 Hi: $-1.30
5 analysts +1q $-0.39
Lo: $-0.39 Hi: $-0.39
1 analysts ▲1
0q $-0.39
Lo: $-0.39 Hi: $-0.39
1 analysts ▲1
0y $-1.56
Lo: $-1.56 Hi: $-1.56
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days